Alzheimer’s drug requires strengthened pharmacovigilance approach
By Catherine Eckford (European Pharmaceutical Review)
Vulnerable medicine list to aid US medicine supply resilience
By Catherine Eckford (European Pharmaceutical Review)
CHMP meeting highlights – February 2025
By Catherine Eckford (European Pharmaceutical Review)
Sustainable method converting waste into pharmaceuticals developed
By European Pharmaceutical Review
Preparing for a new era in the rare disease sector
By Catherine Eckford (European Pharmaceutical Review), Christina Gkousgkouni (Sanofi)
Harnessing industry advancements to accelerate upstream process development
By Dr Li Yang (Altruist Biologics), Dr Shidong Shi (Altruist…